| Table 5: | ||
|
Interaction
of Factor V Leiden and Oral Contraceptive Pill (OCP) Use in the Relative
Risk of Venous Thromboembolic Disease
|
||
|
|
Relative
Risk |
Absolute
Risk* |
| Noncarrier women |
1
|
0.8/10000
|
| Noncarrier women on OCP |
4
|
3.2/10000
|
| Factor V Leiden heterozygosity |
7
|
5.7/10000
|
| Factor
V Leiden heterozygous woman on OCP |
35
|
28.5/10000
|
| *Estimated number of cases of VTE per 10000 persons per year.28 | ||
|
Copyright
2003 The Cleveland Clinic Foundation
|
Return to Hypercoagulable States Chapter